Qube Research & Technologies (QRT)
AUGX

Qube Research & Technologies (QRT)’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,273
Closed -$35.9K – 3918
2024
Q3 		$35.9K Sell
15,273
-160
-1% -$323 ﹤0.01% 2909
2024
Q2 		$13.6K Sell
15,433
-206,567
-93% -$426K ﹤0.01% 2934
2024
Q1 		$908K Buy
222,000
+120,729
+119% +$540K ﹤0.01% 2197
2023
Q4 		$592K Buy
101,271
+96,562
+2,051% +$508K ﹤0.01% 2197
2023
Q3 		$24.3K Buy
+4,709
New +$22.1K ﹤0.01% 3091

Qube Research & Technologies (QRT)'s AUGX Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 15,273 shares — an estimated $35.9K sold.

Qube Research & Technologies (QRT) first reported a position in AUGX in Q3 2023 and held it in 5 quarters. The position peaked at $908K in Q1 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 15,273 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $35.9K.
  • Qube Research & Technologies (QRT) first reported a position in Augmedix, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Augmedix, Inc. Common Stock position peaked at $908K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.